Xenetic Biosciences Q1 EPS $(0.20) Up From $(0.59) YoY, Sales $806.923K Up From $593.261K YoY

Benzinga Newsdesk www.benzinga.com Negative 81.6%

Neg 81.6% Neu 0% Pos 0%

Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.20) per share. This is a 66.1 percent increase over losses of $(0.59) per share from the same period last year. The company reported $806.923 thousand in sales this quarter. This is a 36.01 percent increase over sales of $593.261 thousand the same period last year.